Antiepileptic drug-induced osteopenia in ambulatory epileptic children receiving a standard vitamin D3 supplement
dc.contributor.author | Tekgul H. | |
dc.contributor.author | Dizdarer G. | |
dc.contributor.author | Demir N. | |
dc.contributor.author | Ozturk C. | |
dc.contributor.author | Tutuncuoglu S. | |
dc.date.accessioned | 2019-10-27T00:11:27Z | |
dc.date.available | 2019-10-27T00:11:27Z | |
dc.date.issued | 2005 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Dual energy X-ray absorptiometry (DEXA) is a non-invasive, rapid, accurate and highly reproducible method for the assessment of antiepileptic drug (AED)-induced osteopenia in epileptic children. In this study, we investigated bone mineral density (BMD) using DEXA in 56 epileptic children receiving long-term AED treatment for at least 2 years. All children received AED monotherapy or polytherapy plus a standard vitamin D3 supplement (400 U/day). BMD measurements were made from lumbar spine (L2-L4) regions. Age- and sex-specific BMD SD scores were calculated for each child. Osteopenia was defined as SD scores less than -1.5. There was no significant difference in mean BMD values between epileptic children receiving monotherapy or polytherapy. The results were also compared to the age- and sex-specific BMD SD scores obtained from healthy Turkish children. Only three patients (5%) receiving AED therapy had a BMD SD score less than -1.5. This rate is relatively lower than the rates of previous studies conducted on ambulatory children on long-term AED treatment without vitamin D3 supplementation. © Freund Publishing House Ltd., London. | en_US |
dc.identifier.doi | 10.1515/JPEM.2005.18.6.585 | en_US |
dc.identifier.endpage | 588 | en_US |
dc.identifier.issn | 0334-018X | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 16042326 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 585 | en_US |
dc.identifier.uri | https://doi.org/10.1515/JPEM.2005.18.6.585 | |
dc.identifier.uri | https://hdl.handle.net/11454/22178 | |
dc.identifier.volume | 18 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Freund Publishing House Ltd | en_US |
dc.relation.ispartof | Journal of Pediatric Endocrinology and Metabolism | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Antiepileptic drug | en_US |
dc.subject | Bone mineral density | en_US |
dc.subject | Epilepsy | en_US |
dc.subject | Osteopenia | en_US |
dc.subject | Vitamin D | en_US |
dc.title | Antiepileptic drug-induced osteopenia in ambulatory epileptic children receiving a standard vitamin D3 supplement | en_US |
dc.type | Article | en_US |